Literature DB >> 30523057

False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms.

Rebecca L King1, Ellen D McPhail2, Reid G Meyer3, George Vasmatzis4, Kathryn Pearce3, James B Smadbeck4, Rhett P Ketterling2,3, Stephanie A Smoley3, Patricia T Greipp3, Nicole L Hoppman3, Jess F Peterson3, Linda B Baughn3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30523057      PMCID： PMC6545835          DOI： 10.3324/haematol.2018.207290

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Detection of cryptic and variant IGH-MYC rearrangements in high-grade non-Hodgkin's lymphoma by fluorescence in situ hybridization: implications for cytogenetic testing.

Authors:  Philippa C May; Nicola Foot; Robert Dunn; Helen Geoghegan; Michael J Neat
Journal:  Cancer Genet Cytogenet       Date:  2010-04-01

2.  MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study.

Authors:  Christiane Copie-Bergman; Peggy Cuillière-Dartigues; Maryse Baia; Josette Briere; Richard Delarue; Danielle Canioni; Gilles Salles; Marie Parrens; Karim Belhadj; Bettina Fabiani; Christian Recher; Tony Petrella; Nicolas Ketterer; Frederic Peyrade; Corinne Haioun; Inga Nagel; Reiner Siebert; Fabrice Jardin; Karen Leroy; Jean-Philippe Jais; Herve Tilly; Thierry Jo Molina; Philippe Gaulard
Journal:  Blood       Date:  2015-09-15       Impact factor: 22.113

3.  MYC status determination in aggressive B-cell lymphoma: the impact of FISH probe selection.

Authors:  Ana M Muñoz-Mármol; Carolina Sanz; Gustavo Tapia; Ruth Marginet; Aurelio Ariza; José L Mate
Journal:  Histopathology       Date:  2013-06-24       Impact factor: 5.087

4.  MYC translocation partner gene determines survival of patients with large B-cell lymphoma with MYC- or double-hit MYC/BCL2 translocations.

Authors:  Mette Ø Pedersen; Anne O Gang; Tim S Poulsen; Helle Knudsen; Anne F Lauritzen; Signe L Nielsen; Tobias W Klausen; Peter Nørgaard
Journal:  Eur J Haematol       Date:  2013-11-11       Impact factor: 2.997

5.  BIMA V3: an aligner customized for mate pair library sequencing.

Authors:  Travis M Drucker; Sarah H Johnson; Stephen J Murphy; Kendall W Cradic; Terry M Therneau; George Vasmatzis
Journal:  Bioinformatics       Date:  2014-02-12       Impact factor: 6.937

6.  Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Authors:  Alexandar Tzankov; Zijun Y Xu-Monette; Marc Gerhard; Carlo Visco; Stephan Dirnhofer; Nora Gisin; Karen Dybkaer; Attilio Orazi; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Maurilio Ponzoni; Andrés J M Ferreri; Qing Ye; Jane N Winter; John P Farnen; Miguel A Piris; Michael B Møller; M James You; Timothy McDonnell; L Jeffrey Medeiros; Ken H Young
Journal:  Mod Pathol       Date:  2013-12-13       Impact factor: 7.842

7.  SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq).

Authors:  Sarah H Johnson; James B Smadbeck; Stephanie A Smoley; Athanasios Gaitatzes; Stephen J Murphy; Faye R Harris; Travis M Drucker; Roman M Zenka; Beth A Pitel; Ross A Rowsey; Nicole L Hoppman; Umut Aypar; William R Sukov; Robert B Jenkins; Andrew L Feldman; Hutton M Kearney; George Vasmatzis
Journal:  Cancer Genet       Date:  2017-12-02

8.  Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2.

Authors:  R R Einerson; M E Law; H E Blair; P J Kurtin; R F McClure; R P Ketterling; H C Flynn; A Dogan; E D Remstein
Journal:  Leukemia       Date:  2006-08-03       Impact factor: 11.528

9.  C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.

Authors:  Narendranath Epperla; Kami J Maddocks; Mohammed Salhab; Julio C Chavez; Nishitha Reddy; Reem Karmali; Elvira Umyarova; Veronika Bachanova; Cristiana Costa; Martha Glenn; Oscar Calzada; Ana C Xavier; Zheng Zhou; Nasheed M Hossain; Francisco J Hernandez-Ilizaliturri; Zeina Al-Mansour; Stefan K Barta; Saurabh Chhabra; Frederick Lansigan; Amitkumar Mehta; Michael V Jaglal; Andrew M Evens; Christopher R Flowers; Jonathon B Cohen; Timothy S Fenske; Mehdi Hamadani; Luciano J Costa
Journal:  Cancer       Date:  2017-07-27       Impact factor: 6.860

10.  Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.

Authors:  Qing Ye; Zijun Y Xu-Monette; Alexandar Tzankov; Lijuan Deng; Xiaoxiao Wang; Ganiraju C Manyam; Carlo Visco; Santiago Montes-Moreno; Li Zhang; Karen Dybkær; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Ben M Parsons; Michael B Møller; Miguel A Piris; Jane N Winter; L Jeffrey Medeiros; Shimin Hu; Ken H Young
Journal:  Oncotarget       Date:  2016-01-19
View more
  10 in total

1.  The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH.

Authors:  Laura K Hilton; Jeffrey Tang; Susana Ben-Neriah; Miguel Alcaide; Aixiang Jiang; Bruno M Grande; Christopher K Rushton; Merrill Boyle; Barbara Meissner; David W Scott; Ryan D Morin
Journal:  Blood       Date:  2019-10-31       Impact factor: 22.113

Review 2.  Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma.

Authors:  Rebecca L King; Eric D Hsi; Wing C Chan; Miguel A Piris; James R Cook; David W Scott; Steven H Swerdlow
Journal:  Virchows Arch       Date:  2022-09-03       Impact factor: 4.535

3.  Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma.

Authors:  Carla Fuster; David Martín-Garcia; Olga Balagué; Alba Navarro; Ferran Nadeu; Dolors Costa; Miriam Prieto; Itziar Salaverria; Blanca Espinet; Alfredo Rivas-Delgado; Maria José Terol; Eva Giné; Pilar Forcada; Margaret Ashton-Key; Xose S Puente; Steven H Swerdlow; Sílvia Beà; Elias Campo
Journal:  Haematologica       Date:  2019-11-21       Impact factor: 9.941

4.  Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements.

Authors:  Jess F Peterson; Beth A Pitel; Stephanie A Smoley; George Vasmatzis; James B Smadbeck; Patricia T Greipp; Rhett P Ketterling; William R Macon; Linda B Baughn
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-06-03

5.  Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.

Authors:  Blanca Gonzalez-Farre; Joan Enric Ramis-Zaldivar; Julia Salmeron-Villalobos; Olga Balagué; Verónica Celis; Jaime Verdu-Amoros; Ferran Nadeu; Constantino Sábado; Antonio Ferrández; Marta Garrido; Federico García-Bragado; María Dolores de la Maya; José Manuel Vagace; Carlos Manuel Panizo; Itziar Astigarraga; Mara Andrés; Elaine S Jaffe; Elias Campo; Itziar Salaverria
Journal:  Haematologica       Date:  2019-02-07       Impact factor: 9.941

6.  Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.

Authors:  James Smadbeck; Jess F Peterson; Kathryn E Pearce; Beth A Pitel; Andrea Lebron Figueroa; Michael Timm; Dragan Jevremovic; Min Shi; A Keith Stewart; Esteban Braggio; Daniel L Riggs; P Leif Bergsagel; George Vasmatzis; Hutton M Kearney; Nicole L Hoppman; Rhett P Ketterling; Shaji Kumar; S Vincent Rajkumar; Patricia T Greipp; Linda B Baughn
Journal:  Blood Cancer J       Date:  2019-12-16       Impact factor: 11.037

Review 7.  Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.

Authors:  Renata Woroniecka; Grzegorz Rymkiewicz; Lukasz M Szafron; Katarzyna Blachnio; Laura A Szafron; Zbigniew Bystydzienski; Barbara Pienkowska-Grela; Klaudia Borkowska; Jolanta Rygier; Aleksandra Kotyl; Natalia Malawska; Katarzyna Wojtkowska; Joanna Parada; Anita Borysiuk; Victor Murcia Pienkowski; Malgorzata Rydzanicz; Beata Grygalewicz
Journal:  PLoS One       Date:  2022-02-15       Impact factor: 3.240

8.  MYC break-apart FISH probe set reveals frequent unbalanced patterns of uncertain significance when evaluating aggressive B-cell lymphoma.

Authors:  Linda B Baughn; Jess F Peterson; Marie-France Gagnon; Kathryn E Pearce; Patricia T Greipp; Xinjie Xu; Nicole L Hoppman; Rhett P Ketterling; Ellen D McPhail; Rebecca L King
Journal:  Blood Cancer J       Date:  2021-11-24       Impact factor: 11.037

9.  The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma.

Authors:  Neeraj Sharma; James B Smadbeck; Nadine Abdallah; Cinthya Zepeda-Mendoza; Moritz Binder; Kathryn E Pearce; Yan W Asmann; Jess F Peterson; Rhett P Ketterling; Patricia T Greipp; P Leif Bergsagel; S Vincent Rajkumar; Shaji K Kumar; Linda B Baughn
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

10.  Clinical Interest of LMO2 Testing for the Diagnosis of Aggressive Large B-Cell Lymphomas.

Authors:  Ivonne Vazquez; Natalia Papaleo; Eugenia Garcia; Marta Salido; Antonio Salar; Silvia Hernandez; Xavier Calvo; Luis Colomo
Journal:  Cancers (Basel)       Date:  2020-04-05       Impact factor: 6.639
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.